SUMMARY
Clostridium difficile
is a formidable nosocomial and community-acquired pathogen, causing clinical presentations ranging from asymptomatic colonization to self-limiting diarrhea to toxic megacolon and fulminant colitis. Since the early 2000s, the incidence of
C. difficile
disease has increased dramatically, and this is thought to be due to the emergence of new strain types. For many years, the mainstay of
C. difficile
disease diagnosis was enzyme immunoassays for detection of the
C. difficile
toxin(s), although it is now generally accepted that these assays lack sensitivity. A number of molecular assays are commercially available for the detection of
C. difficile
. This review covers the history and biology of
C. difficile
and provides an in-depth discussion of the laboratory methods used for the diagnosis of
C. difficile
infection (CDI). In addition, strain typing methods for
C. difficile
and the evolving epidemiology of colonization and infection with this organism are discussed. Finally, considerations for diagnosing
C. difficile
disease in special patient populations, such as children, oncology patients, transplant patients, and patients with inflammatory bowel disease, are described. As detection of
C. difficile
in clinical specimens does not always equate with disease, the diagnosis of
C. difficile
infection continues to be a challenge for both laboratories and clinicians.